Status:

COMPLETED

PMCF Retrospective Study Outcomes of a Premium Monofocal IOL

Lead Sponsor:

Beaver-Visitec International, Inc.

Collaborating Sponsors:

targomedGmbH

Conditions:

Cataract

Lens Opacities

Eligibility:

All Genders

45+ years

Phase:

NA

Brief Summary

Multicentric, retro- / prospective, open-label, observational PMCF study to investigate visual performance, contrast sensitivity and patient satisfaction after mono- or bilateral implantation of Isopu...

Detailed Description

The study is a multicentric, retro- / prospective, open-label, observational PMCF study to investigate visual performance, contrast sensitivity and patient satisfaction after mono- or bilateral implan...

Eligibility Criteria

Inclusion

  • • Male or female adults ages 45 years or older on the day of treatment that were mono- or bilaterally implanted with Isopure 1.2.3. intraocular lens minimum 120 days before the study visit;
  • Maximum time between first and second eye treatment: 45 days (this accounts for bilateral implantations only);
  • Capability to understand and sign an IRB approved informed consent form and privacy authorization;
  • Clear intraocular media;
  • Minimum set of retrospective preoperative and intraoperative data available as outlined in the examination matrix;
  • Willing and able to conform to the study requirements.

Exclusion

  • • Age of patient \<45 years at the day of surgery;
  • Time between first and second eye treatment: \>45 days (this accounts for bilateral implantations only);
  • Subjects who underwent previous intraocular or corneal surgery other than IOL implantation;
  • Subjects with diagnosed degenerative visual disorders (e.g. AMD or CME);
  • Subjects in whom in-the-bag implantation was not possible;
  • Subjects in whom surgical complications occurred (e.g. posterior rupture).
  • Subjects showing glaucoma;

Key Trial Info

Start Date :

May 24 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 12 2022

Estimated Enrollment :

109 Patients enrolled

Trial Details

Trial ID

NCT04874376

Start Date

May 24 2021

End Date

January 12 2022

Last Update

July 20 2022

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Oftalvist, Alicante

Alicante, Spain

2

Vithas, Alicante

Alicante, Spain

3

Clinica Baviera

Madrid, Spain

4

HM Monteprincipe

Madrid, Spain